The latest products released on the market for Quarter 2 2021.
Improvements in technology are fundamental to providing the highest level of patient care in radiology. To meet that goal, industry vendors are constantly developing new tools and equipment that provide better image quality, greater diagnostic potential, and significant improvements in comfort for both provider and patient.
In this Product Showcase, Diagnostic Imaging brings you the latest product offerings released each quarter, including details about product specifications and their potential impacts and benefits. This quarter, we bring you new products from Konica Minolta, GE Healthcare, Volpara Health, Carestream, PaxeraHealth, KA Imaging, Esaote, UltraSight, Intelerad, and United Imaging.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.